Lutz, T., Lampert, A., Hoffmann, G. F., & Ries, M. (2016). Novel treatments for rare rheumatologic disorders: Analysis of the impact of 30 years of the US orphan drug act. BioMed Central.
Chicago-Zitierstil (17. Ausg.)Lutz, Thomas, Anette Lampert, Georg F. Hoffmann, und Markus Ries. Novel Treatments for Rare Rheumatologic Disorders: Analysis of the Impact of 30 Years of the US Orphan Drug Act. London: BioMed Central, 2016.
MLA-Zitierstil (9. Ausg.)Lutz, Thomas, et al. Novel Treatments for Rare Rheumatologic Disorders: Analysis of the Impact of 30 Years of the US Orphan Drug Act. BioMed Central, 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.